Dr. Sangiorgi graduated in Medicine and Surgery in 1990 from the University of Rome “Tor Vergata”.
He then specialized in Cardiology at the same University in 1990. He held the role of Fellow in Interventional Cardiology and Research Associate at the Haemodynamics Laboratory of the Mayo Clinic and Foundation in Rochester (USA) from 1991 to 1998.
Back in Italy, he became Assistant at the Cardiovascular Interventional Radiology Laboratory of the San Donato Polyclinic Institute from 1998 to 2002, while from 2003 to 2009 he was Co-Director at the Columbus Heart Center and the Hemodynamics Laboratory of the San Raffaele Hospital in Milan. Between 2009 and 2011 he worked as Head of the Hemodynamics Laboratory of the Modena Polyclinic, while in the following three years he worked at the Casilino Polyclinic in Rome. Since 2014 he has been part of the GVM group and works at various private and accredited facilities throughout the country. Dr. Sangiorgi has been a confirmed Researcher since 1998, and in 2010 he obtained the qualification to Associate Professor of Cardiology at the University of Padua. He is Professor of Cardiovascular Pathology at the School of Specialization in Pathological Anatomy of the University of Tor Vergata and Contract Professor for the Peripheral Interventional Course at the Department of Vascular Surgery of the University of Sassari. He is also the author of 270 works in national and international journals, 50 book chapters and approximately 900 abstracts .
Education and Training
Associations and Scientific Societies
Scientific Activity
Dr. Sangiorgi's scientific activity mainly concerns the pathology and physiopathology of the cardiovascular system, with particular reference to coronary and carotid atherosclerotic disease and restenosis after interventional procedures. Furthermore, Dr. Sangiorgi has constantly dealt with issues related to interventional cardiology with particular reference to the medium and long-term results of the use of various platforms of implantable medical devices.
In carrying out these activities he used anatomo-pathological, histochemical and ultrastructural methods. He also dedicated himself particularly to morphometric techniques applied to cardiovascular pathology.
Since September 1993 he has had the opportunity to dedicate himself, at the Mayo Clinic in Rochester (USA), in the Laboratory of Experimental Interventional Cardiology directed by Dr. Robert Schwartz, to the study of the morphology, physiopathology and pathology of restenosis and vascular remodeling mechanical revascularization interventions.
His research focuses on the following main themes:
The research carried out mainly concerned the development of new methods:
In particular, his studies concerned:
Dr. Giuseppe Sangiorgi has also participated in the following Research Projects in competition of the National Research Center, National Committee for Biological and Medical Sciences:
Professional Assignments
Research Activities Abroad
Scientific Awards and Recognitions
Editorial and Corporate Assignments
Awards and Recognitions
In 1998 he received the third prize as “ Young Researcher ” from the American Heart Association for the discovery of cellular apoptosis in aortic valves in patients affected by aortic stenosis and the first prize from the Italian Society of Cardiology as “Young Researcher” for the discovery of a new serum marker for the risk of STROKE in December 2001.
Lire la suiteDr. Sangiorgi graduated in Medicine and Surgery in 1990 from the University of Rome “Tor Vergata”.
He then specialized in Cardiology at the same University in 1990. He held the role of Fellow in Interventional Cardiology and Research Associate at the Haemodynamics Laboratory of the Mayo Clinic and Foundation in Rochester (USA) from 1991 to 1998.
Back in Italy, he became Assistant at the Cardiovascular Interventional Radiology Laboratory of the San Donato Polyclinic Institute from 1998 to 2002, while from 2003 to 2009 he was Co-Director at the Columbus Heart Center and the Hemodynamics Laboratory of the San Raffaele Hospital in Milan. Between 2009 and 2011 he worked as Head of the Hemodynamics Laboratory of the Modena Polyclinic, while in the following three years he worked at the Casilino Polyclinic in Rome. Since 2014 he has been part of the GVM group and works at various private and accredited facilities throughout the country. Dr. Sangiorgi has been a confirmed Researcher since 1998, and in 2010 he obtained the qualification to Associate Professor of Cardiology at the University of Padua. He is Professor of Cardiovascular Pathology at the School of Specialization in Pathological Anatomy of the University of Tor Vergata and Contract Professor for the Peripheral Interventional Course at the Department of Vascular Surgery of the University of Sassari. He is also the author of 270 works in national and international journals, 50 book chapters and approximately 900 abstracts .
Education and Training
Associations and Scientific Societies
Scientific Activity
Dr. Sangiorgi's scientific activity mainly concerns the pathology and physiopathology of the cardiovascular system, with particular reference to coronary and carotid atherosclerotic disease and restenosis after interventional procedures. Furthermore, Dr. Sangiorgi has constantly dealt with issues related to interventional cardiology with particular reference to the medium and long-term results of the use of various platforms of implantable medical devices.
In carrying out these activities he used anatomo-pathological, histochemical and ultrastructural methods. He also dedicated himself particularly to morphometric techniques applied to cardiovascular pathology.
Since September 1993 he has had the opportunity to dedicate himself, at the Mayo Clinic in Rochester (USA), in the Laboratory of Experimental Interventional Cardiology directed by Dr. Robert Schwartz, to the study of the morphology, physiopathology and pathology of restenosis and vascular remodeling mechanical revascularization interventions.
His research focuses on the following main themes:
The research carried out mainly concerned the development of new methods:
In particular, his studies concerned:
Dr. Giuseppe Sangiorgi has also participated in the following Research Projects in competition of the National Research Center, National Committee for Biological and Medical Sciences:
Professional Assignments
Research Activities Abroad
Scientific Awards and Recognitions
Editorial and Corporate Assignments
Awards and Recognitions
In 1998 he received the third prize as “ Young Researcher ” from the American Heart Association for the discovery of cellular apoptosis in aortic valves in patients affected by aortic stenosis and the first prize from the Italian Society of Cardiology as “Young Researcher” for the discovery of a new serum marker for the risk of STROKE in December 2001.
Dr. Ahmed then, traveled to the Italian city of Modena to prepare the Fellowship of Interventional Cardiology and Endovascular therapy from the University of Modena and Reggo Emelia, where he was appointed as a lecturer for postgraduate students, in Interventional Cardiology. Then he traveled to Milan, Italy, in 2012 to prepare a fellowship in structural heart diseases.
The Journey continues to the Japanese city of Tokyo in the year 2013 to start training in the field of chronic total coronary oclusions and complex interventions. Finally, he returned to Cairo in 2013, where he obtained a doctorate degree in the field of cardiovascular medicine from Ain Shams University.
Member of the European Heart Association since 2007.
Dr. Ahmed attended many international medical conferences and was a lecturer in several important international forums.
He contributed to publishing important books, articles and medical research in international magazines.
Dr. Ahmed then, traveled to the Italian city of Modena to prepare the Fellowship of Interventional Cardiology and Endovascular therapy from the University of Modena and Reggo Emelia, where he was appointed as a lecturer for postgraduate students, in Interventional Cardiology. Then he traveled to Milan, Italy, in 2012 to prepare a fellowship in structural heart diseases.
The Journey continues to the Japanese city of Tokyo in the year 2013 to start training in the field of chronic total coronary oclusions and complex interventions. Finally, he returned to Cairo in 2013, where he obtained a doctorate degree in the field of cardiovascular medicine from Ain Shams University.
Member of the European Heart Association since 2007.
Dr. Ahmed attended many international medical conferences and was a lecturer in several important international forums.
He contributed to publishing important books, articles and medical research in international magazines.
Dr Mahmoud El-Alfy is a one of Sphinx Chairman & Consultant nephrology & renal clinical transplantation
The Doctor leads a highly skilled team ensuring top-tier professional care
Dr achieved to make his center is the only center in Africa and one of two in the Middle East recognized by top pharmacological companies for training health professionals in the Immunology and Transplantation Centre.
Our elite consultants provide online and in-person consultation via our clinics and we have several collaboration protocols with transplant and kidney centers in Africa and the Middle East.
Partners in success with:
DaVita, Diaverum , Baxter, Fresenius Medical care, Roche, Novartis, CHU Grenoble, EG PHYSIO
Our Mission
To Provide an integrated pattern of renal care service through implementation of patient-centered and comprehensive services while continuously seeking innovative advancement to meet the unique needs of our patients.
Continuous Medical Education by collaboration with most advanced professional centers in Europe in renal Transplantation and Desensitization Grenoble hospital university.
We are exchanging our experience with different centers in
Dr Mahmoud El-Alfy is a one of Sphinx Chairman & Consultant nephrology & renal clinical transplantation
The Doctor leads a highly skilled team ensuring top-tier professional care
Dr achieved to make his center is the only center in Africa and one of two in the Middle East recognized by top pharmacological companies for training health professionals in the Immunology and Transplantation Centre.
Our elite consultants provide online and in-person consultation via our clinics and we have several collaboration protocols with transplant and kidney centers in Africa and the Middle East.
Partners in success with:
DaVita, Diaverum , Baxter, Fresenius Medical care, Roche, Novartis, CHU Grenoble, EG PHYSIO
Our Mission
To Provide an integrated pattern of renal care service through implementation of patient-centered and comprehensive services while continuously seeking innovative advancement to meet the unique needs of our patients.
Continuous Medical Education by collaboration with most advanced professional centers in Europe in renal Transplantation and Desensitization Grenoble hospital university.
We are exchanging our experience with different centers in